participant,SRS2_resp,SRS2_RT,SRS2_item,SRS2_scoring_type,SRS2_treatment_subscale
94,2,4,1,positive,mot
94,2,4.548,2,positive,awr
94,2,3.495,3,negative,mot
94,2,7.943,4,positive,rrb
94,2,4.892,5,positive,cog
94,3,2.163,6,positive,mot
94,3,2.644,7,negative,awr
94,2,5.926,8,positive,rrb
94,1,2.546,9,positive,mot
94,1,3.031,10,positive,cog
94,2,1.819,11,negative,mot
94,2,3.603,12,negative,com
94,2,4.79,13,positive,com
94,1,1.566,14,positive,rrb
94,3,4.426,15,negative,cog
94,1,2.314,16,positive,com
94,3,3.269,17,negative,cog
94,4,3.546,18,positive,com
94,2,2.291,19,positive,com
94,1,4.78,20,positive,rrb
94,3,5.577,21,negative,com
94,3,1.86,22,negative,com
94,1,5.277,23,positive,mot
94,2,2.76,24,positive,rrb
94,2,3.743,25,positive,awr
94,2,2.182,26,negative,com
94,1,2.232,27,positive,mot
94,1,3.567,28,positive,rrb
94,1,2.196,29,positive,rrb
94,1,2.801,30,positive,cog
94,1,2.06,31,positive,rrb
94,4,1.684,32,negative,awr
94,2,3.292,33,positive,com
94,1,2.428,34,positive,mot
94,1,1.999,35,positive,com
94,1,2.269,36,positive,com
94,1,2.665,37,positive,com
94,2,3.138,38,negative,com
94,1,2.36,39,positive,rrb
94,2,2.743,40,negative,cog
94,1,4.577,41,positive,com
94,1,1.312,42,positive,cog
94,2,2.985,43,negative,mot
94,1,5.299,44,positive,cog
94,2,3.815,45,negative,awr
94,2,2.609,46,positive,com
94,2,1.695,47,positive,com
94,3,1.726,48,negative,cog
94,1,3.467,49,positive,rrb
94,1,1.668,50,positive,rrb
94,1,2.258,51,positive,com
94,2,1.684,52,positive,awr
94,1,3.524,53,positive,com
94,1,2.725,54,positive,awr
94,1,2.859,55,positive,com
94,1,3.817,56,positive,awr
94,2,1.663,57,positive,com
94,2,4.344,58,positive,cog
94,3,1.47,59,positive,cog
94,2,2.534,60,positive,com
94,1,1.645,61,positive,com
94,1,4.158,62,positive,cog
94,1,2.964,63,positive,rrb
94,2,2.242,64,positive,mot
94,3,2.2,65,positive,mot
